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Abstract
Background: Essential tremor (ET) is the most common tremor disorder. ET has classically been viewed as a benign monosymptomatic condition. Yet over the
past 10 years, a growing body of evidence indicates that this is a progressive condition that is clinically heterogeneous, and may be associated with a variety of
different features. Large epidemiological studies such as the Neurological Disorders of Central Spain (NEDICES), a longitudinal, population-based survey, have
contributed significantly to the changing view of the disease. Our aim is to review some of the main results of NEDICES within the larger framework of the
epidemiology of ET.
Methods: Data for this review were gathered from all our articles published up to October 2011 regarding NEDICES study and ‘‘Essential Tremor’’.
Results: We have published 18 articles up to October 2011. The prevalence, incidence, and mortality of ET were analyzed in this cohort. In addition, ET was
found to be associated with increased frailty and low morale, as well as with a series of non-motor manifestations, including cognitive deficits, mild cognitive
impairment, dementia, depressive symptoms, and hearing impairment. Finally, the link between ET and Parkinson’s disease (PD) was formally quantified in the
NEDICES study, which demonstrated that the risk of developing incident PD was 4.3 times higher in prevalent ET cases than in age-matched controls without ET.
Conclusions: This review highlights the contributions of NEDICES towards the advancement of current knowledge of the epidemiology and clinical features of
ET, and emphasizes the importance of population-based studies towards the understanding of complex, ageing-related diseases.
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Introduction
Essential tremor (ET) is considered the most prevalent tremor
disorder. It has traditionally been viewed as a monosymptomatic
disease characterized by kinetic arm tremor.1,2 Yet over the past
decades, a growing body of evidence indicates that ET is a progressive
condition that is clinically heterogeneous, and which seems to be
associated with a variety of different features. Actually this disease is
considered to include several motor features, including tremor and
ataxia, and several non-motor features, including possibly cognitive
impairment and personality disturbances.1,2
Large epidemiological studies, such as the Neurological Disorders of
Central Spain (NEDICES), have contributed significantly to the
changing view of this disease.3–5 The aim of this review was to consider
some of the main results of NEDICES within the larger framework of
ET epidemiology.
Methods
Data for this review were gathered from all our articles published
up to October 2011 regarding NEDICES study and ‘‘Essential
Tremor’’.
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The NEDICES study
The NEDICES study is a longitudinal, population-based survey of
major age-associated neurological conditions of elderly people.3–13
Detailed accounts of the study population and sampling methods have
been published.3,5 The study population was composed of elderly
subjects, >65 years of age, living in three communities in central Spain
(Las Margaritas, Lista and Arévalo). The registered study population
was 6,395, of whom 5,914 were eligible, and 5,278 were enrolled.
As described,3–5 face-to-face evaluations were performed at baseline
(1994–1995) and follow-up (1997–1998). Participants were interviewed
using a questionnaire that elicited data on demographics, neurological
disorders (ET, Parkinson’s disease [PD], stroke, and dementia), current
medications (including those with potential central nervous system
effects e.g., anxiolytics, stimulants, antihistamines), medical conditions
(e.g., diabetes mellitus, hypertension, heart disease), smoking habits,
and alcohol use pattern. Depressive symptoms and use of antidepres-
sant medications were also assessed.
The evaluation of tremor and diagnosis of ET has been described in
detail,6,10 and involved a screening question (‘‘have you ever had
tremor of the head, hands, or legs that has lasted longer than several
days?’’) with 68.6% sensitivity,10 followed by a detailed general
neurological examination by a senior neurologist, including a focused
assessment of postural and kinetic tremors (sustained bilateral arm
extension, bilateral finger–nose–finger maneuver, drawing Archimedes
spirals),and the motor portion of the Unified Parkinson’s Disease
Rating Scale (UPDRS).6,10 For participants who could not be
examined, medical records were obtained from general practitioners,
from inpatient hospitalizations, and from neurological specialists (if
they had visited one). Diagnostic criteria for ET (used in participants
who were examined and in those whose medical records were
reviewed) were similar to those used in a study conducted in Sicily.14
Thus, participants were diagnosed with ET if they had an action
tremor of the head, limbs, or voice without any other recognizable
cause. Second, the tremor had to be of gradual onset (i.e., slow and
progressive) and 1) present for at least 1 year or 2) accompanied by a
family history of the same disorder (at least one reportedly affected
first-degree relative). In addition, on an Archimedes spiral, tremor
severity had to be moderate or greater (rating >2 according to the
Washington Heights-Inwood Genetic Study of ET Rating Scale).15
Participants with tremor related to alcohol withdrawal, hyperthyroid-
ism, anxiety, PD, anti-dopaminergic drug intake, lithium therapy, or
other known causes of tremor were not considered to have ET. If ET
was diagnosed, data on age of onset of tremor were elicited. ET cases
identified by one of the eight NEDICES neurologists (see
Acknowledgments) were subsequently examined independently by
two additional neurologists who examined the participant together.
They were classified as having ET only when the three neurologists
agreed.
The second (i.e., follow-up) evaluation (1997–1998) also included a
neuropsychological test battery, which was implemented by psychol-
ogists, social workers, student nurses, and general physicians, all of
whom had been trained by a senior clinical investigator with expertise
in health sciences research (see Acknowledgements, J.R.-N.).
Results
Currently, we have published 18 NEDICES articles regarding ET.
These articles assessed a variety of epidemiological issues, including the
prevalence, incidence, and mortality of ET. In addition, NEDICES
studies demonstrated that ET was associated with increased frailty, low
morale, and PD. Studies also demonstrated that ET was associated
with a series of non-motor manifestations, including cognitive deficits,
mild cognitive impairment, dementia, depressive symptoms, and
hearing impairment. These studies are summarized in Table 1 and
their data will now be reviewed.
Prevalence and incidence
The NEDICES researchers identified 256 persons (152 females, 104
males) with ET out of 5,278 screened. Thus, the prevalence of ET (age
65 and older) on May 1 1994 was 4.8% (95% confidence interval
[CI]54.2–5.4); for males, the prevalence was 4.6% (95% CI53.7–5.4)
and for females it was 5.0% (95% CI54.2–5.8).6 The prevalence
increased with advancing age for both males and females.6 Of 256
prevalent ET cases, 87 (34.0%) reported having an affected relative,
and 204 (79.7%) were detected through the NEDICES screening and
had not been diagnosed prior to the NEDICES study.
To estimate the incidence of ET, the ET-free cohort was evaluated
at follow-up (a median of 3.3 years after the initial assessment in 1997
to 1998). Eighty-three incident ET cases were identified among 3,942
individuals assessed at follow-up. The adjusted annual incidence (per
100,000 person-years) in the population aged 65 years and older was
616 (95% CI5447–784).10 Sixty-four (77.1%) of 83 incident cases
were detected through the NEDICES study and had not been
diagnosed by a physician prior to the NEDICES study assessment.
The point estimates for incidence increased with age, until the oldest
age stratum, and no gender differences in incidence were found.10
These incidence data represent the only population-based incidence
data on ET.
Mortality
Outside of the NEDICES study, there have been no population-
based and no prospectively collected data on mortality in ET. Also,
there have been other studies comparing mortality in ET cases to that
of a simultaneously enrolled control group. In the NEDICES study,
the risk of mortality was assessed and was found to be slightly yet
significantly increased in ET. Specifically, there were 33 (16.4%)
deaths among 201 ET cases and 465 (13.9%) among 3,337 controls at
follow-up 3 years after baseline assessment.16 In an unadjusted Cox
model, the risk of mortality was increased in ET (RR51.59, 95%
CI51.11–2.27, p50.01).16 In a Cox model that adjusted for baseline
age, gender, educational category, current alcohol drinking, use of
antidepressant medication, and community, RR51.45, 95% CI5
1.01–2.08, p50.04.16 In an adjusted Cox model restricted to persons
with longer (.3 years) follow-up, RR54.69 (95% CI52.18–10.07,
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Table 1. Main Results Regarding Essential Tremor in NEDICES Study
Results Comments
Prevalence Overall: 4.8% (95% CI54.2–5.4). 34% of the ET cases had an affected relative
and 79.7% were detected through the
NEDICES study and had not been diagnosed
by a physician prior to the NEDICES study
assessment.
Men: 4.6% (95% CI53.7–5.4).
Women: 5.0% (95% CI54.2–5.8).
Incidence 616 per 100,000 person-years (95% CI5447–784) 77% of incident cases were detected through
the NEDICES study and had not been
diagnosed by a physician prior to the
NEDICES study assessment.
Mortality Unadjusted RR51.59, 95% CI51.11–2.27, p50.01). ET may be a disease not only of increased
morbidity but of increased mortality as well.
Adjusted RR51.45, (95% CI51.01–2.08, p50.04).
Frailty A 20-item frailty score, which assessed comorbid conditions,
number of medications, and functional activity was higher in
ET cases than in controls (8.6¡5.2 vs. 6.8¡4.6, p,0.001)
This study suggests that there may be an
additional frailty syndrome in ET that is above




The Philadelphia Geriatric Center Morale Scale score was
lower in ET cases than controls (9.41¡3.21 vs. 10.39¡2.92,
p,0.001)





Prevalent ET cases were twice more likely than controls to
report depression and three times more likely to be taking
antidepressant medications. In prospective analyses, baseline
self-reported depression and, perhaps, baseline use of
antidepressant medication were associated with incident ET.




ET cases performed less well than controls especially on tests
of global cognitive performance and frontal executive
function. Lower cognitive test scores were associated with
more reported functional difficulty. During the 3-year follow-
up period, baseline cognitive test scores declined at a rate
that was seven-times faster in ET cases than controls
A frontosubcortical-type dysfunction occurs in
some ET patients. Lower cognitive test scores
in ET, rather than being clinically inconse-
quential, seem to have a clinical-functional
correlate.
MCI ET cases with tremor onset after age 65 years were 57%
more likely to have mild cognitive impairment than controls
(OR51.57, 95% CI51.03–2.38, p50.03).
Elderly-onset ET may be associated with MCI
Prevalent
dementia
ET cases with tremor onset after age 65 were 70% more
likely to be demented than were controls (OR51.70, 95%
CI51.04–2.76, p50.03).




ET cases with tremor onset after age 65 years were twice as
likely to develop incident dementia than were controls
(RR51.98, 95% CI51.14 -3.45, p50.01).





ET cases were four times more likely than controls to
develop incident PD during prospective follow-up.
The link between ET and incident PD has for
the first time been formally quantified
The NEDICES Study and Essential Tremor Romero JP, Benito-León J, Bermejo-Pareja F
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services3
p50.001).16 These data suggest that ET is a disease not only of
increased morbidity but of increased mortality as well. Additional
studies are needed to confirm these results.
Frailty
Although ET has been associated with a variety of comorbidities
(hearing impairment, cancer, and depressive symptoms), frailty had
not been studied in ET prior to NEDICES. Data collected during the
NEDICES evaluations were compiled, and a 20-item frailty score was
constructed, which assessed comorbid conditions, number of medica-
tions, and functional activity.17 The frailty score was compared in 237
non-demented elderly ET cases and 3,903 non-demented age-matched
controls from the NEDICES.17 The frailty score was higher in ET
cases than in controls (8.6¡5.2 vs. 6.8¡4.6, p,0.001).17 Stratifying
the frailty score into quartiles and tertiles similarly revealed case–
control differences (both p,0.001).17 The frailty score also increased
with age (r50.25, p,0.001), was higher in females than males
(p50.02), was correlated with subjective rating of health status
(r50.42, p,0.001), and was inversely correlated with body weight
(r520.06, p,0.001) and hours/day that participants performed
moderate or intensive physical activities (r520.16, p,0.001).17
Although ET has previously been associated with several comorbid-
ities, this study demonstrated the presence of case–control differences
in additional comorbidities, medication usage, self-reported limita-
tions, and functional activities, suggesting that there may be an
additional frailty syndrome in ET that is above and beyond what has
been described previously. Whether this increased frailty is a
contributor to the increased risk of mortality that has been observed
in some studies is a question that deserves further scrutiny.
Subjective well-being
Subjective well-being (morale) was assessed in 187 ET cases and 561
matched controls from NEDICES using the Philadelphia Geriatric
Center Morale Scale (PGCMS) (range 50 low morale to 17), which
included three-dimensions of psychological well-being: agitation,
lonely dissatisfaction, and attitude toward own aging. The PGCMS
score was lower in ET cases than controls (9.41¡3.21 vs. 10.39¡2.92,
p,0.001), as were the Agitation subscore (3.17¡1.71 vs. 3.78¡1.67,
p,0.001) and the Lonely Dissatisfaction subscore (3.75¡1.34 vs.
4.02¡1.24, p,0.05). Nearly one-half of the ET cases were classified as
having low morale compared with only one-third of controls
(p50.006). In a linear regression analysis adjusting for demographic
factors and multiple comorbid conditions, ET cases had a lower
PGCMS score than controls (p,0.001), and exclusion of participants
on antidepressant medication did not change the results. The results of
the study indicated that morale was significantly lower in community-
dwelling ET cases than in matched controls. Detection and possible
treatment of this problem might improve the psychological well-being
of patients with ET.
Depressive symptoms
In NEDICES, self-reported depression and use of antidepressant
medications were evaluated at baseline (1994–1995) and 3 years
later.18 In cross-sectional analyses, prevalent ET cases were twice more
likely than controls to report depression (103 [43.8%] of 235 ET cases
vs. 1,137 [26.0%] of 4,379 controls; adjusted odds ratio OR52.20,
95% CI51.66–2.93, p,0.001) and three times more likely to be taking
antidepressant medications (16 6.8% cases vs. 113 2.6% controls;
adjusted OR53.33, 95% CI51.91–5.82, p50.001).18 In prospective
analyses, baseline self-reported depression (adjusted RR 51.78, 95%
CI51.11–2.89, p50.018) and, perhaps, baseline use of antidepressant
medication (adjusted RR 51.90, 95% CI50.59–6.05, p50.28) were
associated with incident ET.18 This study indicated that, rather than
being totally benign, ET seems to be associated with a mood disorder.





In an adjusted logistic regression analysis participants who
reported hearing impairment were 30% more likely to suffer
from ET than were controls (OR51.3; 95% CI51.01–1.7,
p50.04).
ET may be associated with hearing impairment.
Smoking Smokers were nearly half as likely to have ET as were never
smokers (adjusted OR50.58, p50.004). In addition, baseline
heavy cigarette smoking was also associated with a lower risk
of incident ET (adjusted RR50.29, p50.03)
Smoking may be associated with decreased the
risk of developing ET
Ethanol In an adjusted Cox model, the highest baseline drink-year
quartile doubled the risk of incident ET (RR52.29, p50.018)
Higher levels of chronic ethanol consumption
may be associated with increased the risk of
developing ET
Abbreviations: CI, confidence interval; ET, essential tremor; MCI, mild cognitive impairment; NEDICES, Neurological Disorders of Central Spain; OR, odds ratio; PD,
Parkinson’s disease; RR, relative risk.
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manifestations (i.e., the tremor), the mood disorder could be a primary
feature of the underlying disease, preceding the motor manifestations.
Cognitive function, mild cognitive impairment, and dementia
Two-hundred and thirty-two ET cases and 696 matched controls
(median 75 years) from the NEDICES underwent a neuropsychological
assessment, including tests of global cognitive performance, frontal
executive function, verbal fluency, and memory.19 Fifty-six ET cases
were first diagnosed with ET during the NEDICES evaluation and
only 14 (6%) were taking medication for tremor.19 Even after
adjusting for age, gender, education, premorbid intelligence,
medications, and depressive symptoms, ET cases performed less
well than controls on most neuropsychological tests, and especially
tests of global cognitive performance (37-item Mini-Mental State
Examination score 527.0¡6.7 in cases vs. 28.9¡5.9 in controls,
p,0.001) and frontal executive function (Trail Making Test number
of errors 58.7¡11.0 in cases vs. 3.8¡7.6 in controls, p,0.001).19
Forgetfulness was reported in 117 (50.4%) ET cases vs. 300 (43.1%)
controls (p50.05).19
The association between mild cognitive impairment and ET had
only been examined in one prior study.20 In NEDICES, all dementia-
free persons with mild cognitive impairment and ET were identified.
Forty-two (20.3%) of 207 ET cases had mild cognitive impairment vs.
399 (16.1%) of 2,472 controls (OR51.32, 95% CI50.93–1.89,
p50.12).21 In a model that adjusted for age, gender, educational
level, smoking, hearing impairment, depressive symptoms or anti-
depressant use, and use of a medication that could potentially affect
cognitive function, ET was associated with mild cognitive impairment
(OR51.28, 95% CI50.88–1.84, p50.19).21 Yet in an adjusted model,
ET cases with tremor onset after age 65 years were 57% more likely to
have mild cognitive impairment than controls (OR51.57, 95%
CI51.03–2.38, p50.03), whereas ET cases with tremor onset prior
to age 65 and controls were equally likely to have mild cognitive
impairment (OR50.73, 95% CI50.34–1.57, p50.43).21
NEDICES provided evidence that the cognitive deficits in ET are
not static, and they appear to be progressing at a faster rate than in
elders without this disease.22 A 37-item version of the Mini-Mental
State Examination (37-MMSE) was administered to 2,319 non-
demented participants (72.4¡5.8 years of age), including 135
prevalent ET cases and 2,184 controls.22 At baseline, the mean 37-
MMSE in cases was 28.8¡5.8 vs. 30.2¡4.8 in controls (p50.02).22
During the 3-year follow-up period, the 37-MMSE declined by
0.70¡3.2 points in cases vs. only 0.11¡3.8 points in controls
(p50.03).22 In analyses that adjusted for age, education, and other
potential confounders, the case–control difference remained robust.22
NEDICES also demonstrated that lower cognitive test scores in ET,
rather than being inconsequential, have a clear clinical–functional
correlate.23 In NEDICES, the 37-MMSE and an 11-item version of
the Pfeffer Functional Activities Questionnaire (FAQ) were adminis-
tered to non-demented ET cases and controls.23 The FAQ was 55.5%
higher (i.e., lower function) in 208 ET cases than 3,616 controls
(2.8¡4.8 vs. 1.8¡4.2, p,0.001).23 Patients reported more difficulty
(i.e., higher FAQ scores) with FAQ items that were cognitive measures
as well as FAQ items that were cognitive-motor in nature.23 In cases, a
lower 37-MMSE was associated with more difficulty on both
cognitively based and cognitive–motor-based FAQ items (p,0.001).23
The association between ET and prevalent dementia had not
previously assessed prior to NEDICES. In NEDICES, 31 (11.4%) of
273 ET cases had prevalent dementia vs. 204 (6.0%) of 3,382 controls
(OR52.00, 95% CI51.34–2.98, p50.001).24 In a model that adjusted
for age, stroke, and educational level, OR51.35, 95% CI50.87–2.18,
and p50.17.24 In an adjusted model, ET cases with tremor onset after
age 65 were 70% more likely to be demented than were controls
(OR51.70, 95% CI51.04–2.76, p50.03), whereas ET cases with
early tremor onset (# age 65) and controls were equally likely to be
demented (OR50.38, 95% CI50.09–1.73, p50.21).24
In longitudinal analyses, non-demented ET cases and controls were
followed prospectively, and the risk of incident dementia was estimated
in ET cases vs. controls using Cox proportional hazards models.25 The
3,891 participants had a mean duration of follow-up of 3.2 years.25
Sixteen (7.8%) of 206 ET cases developed incident dementia vs. 145
(3.9%) of 3,685 controls (unadjusted RR52.08, 95% CI51.24–3.50,
p50.006 and adjusted RR51.66, 95% CI50.99–2.80, p50.054).25 In
an adjusted model, ET cases with tremor onset after age 65 years were
twice as likely to develop incident dementia than were controls
(RR51.98, 95% CI51.14–3.45, p50.01), whereas ET cases with
earlier tremor onset (#age 65) and controls were equally likely to
develop incident dementia (RR50.74, 95% CI50.19–3.20,
p50.79).25
PD
In NEDICES, ET cases were four times more likely than controls to
develop incident PD during prospective follow-up.26 After a median of
3.3 years, 12 (5.8%) of 207 ET cases developed parkinsonism
compared with 56 (1.6%) of 3,606 controls (adjusted RR53.47,
95% CI51.82–6.59, p50.001).26 Six (3.0%) of 201 ET cases
developed incident PD vs. 24 (0.7%) of 3,574 controls (adjusted
RR54.27, 95% CI51.72–10.61; p50.002).26
Hearing impairment
In NEDICES, ET seemed to be associated with reported hearing
impairment.27 Ninety-six (38.7%) of 248 ET cases vs. 1,371 (29.4%) of
4,669 controls (p50.002) reported hearing impairment.27 In a logistic
regression analysis that adjusted for age, gender, educational level,
depressive symptoms, and dementia, participants who reported
hearing impairment were 30% more likely to suffer from ET than
were controls (OR51.3; 95% CI51.01–1.7, p50.04).27
Smoking and ET
In NEDICES, cigarette smoking habits were assessed in 221
prevalent ET cases (75.5¡7.1 years old) and 663 matched controls
(74.6¡7.0 years old),28 and the results suggested that cigarette
smoking might be a protective factor for ET. Those who smoked
were marginally less likely to have ET than those who had never
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smoked (22.0% vs. 27.0%, OR50.76, 95% CI50.55–1.04, p50.09).28
In an analysis that adjusted for confounding factors (drink-years and
depressive symptoms), those who smoked were nearly half less likely to
have ET than those who had never smoked (OR50.58, 95%
CI50.40–0.84, p50.004).28 There was a strong inverse association
between pack-years and odds of ET (adjusted OR50.991, 95%
CI50.984–0.997, p50.005, i.e., with every 10 pack-year increase,
odds of ET were lowered 10%).28
Smokers in the highest pack-year tertile were one-third as likely to
have ET than those who had never smoked (adjusted OR50.39, 95%
CI50.22–0.69, p50.001).28
In prospective analyses, the NEDICES study also demonstrated an
association between baseline heavy cigarette smoking and lower risk of
incident ET.29 Participants were stratified into baseline pack-year
tertiles, and few incident ET cases were in the highest baseline tertile (4
[5.2%] cases vs. 431 [13.2%] controls, p50.039).29 In Cox propor-
tional hazards models, the highest baseline pack-year tertile was
associated with lowest risk of incident ET; those in the highest pack-
year tertile were one-third as likely to develop ET as non-smokers
(RR50.37, 95% CI50.14–1.03, p 50.057 unadjusted model and
RR50.29, 95% CI50.09–0.90, p50.03 adjusted model).29
Drinking alcohol and risk of ET
In NEDICES, higher levels of chronic alcohol consumption seemed
to increase the risk of developing ET.30 In a Cox proportional hazards
model adjusting for cigarette pack-years, depressive symptoms and
community, the baseline number of drink-years was marginally
associated with a higher risk of incident ET (RR51.003, p50.059).
In an adjusted Cox model, the highest baseline drink-year quartile
doubled the risk of incident ET (RR52.29, p50.018), while other
quartiles were associated with more modest elevations in risk (RR in
3rd quartile 51.82, p50.10, RR in 2nd quartile 51.75, p50.10, RR
in lowest quartile 51.43, p50.34 vs. non-drinkers, RR51.00).30 With
each higher drink-year quartile, the risk of incident ET increased an
average of 23% (p50.01, test for trend).30
Antihypertensive drugs and risk of ET
Recent interest in antihypertensive agents, especially calcium
channel blockers, has been sparked by the notion that these
medications may be neuroprotective.31 However, in NEDICES,
baseline use of antihypertensive agents was not associated with
reduced risk of incident ET.32
Discussion
NEDICES and other neuroepidemiological, clinical, and patholo-
gical studies1,33,34 have substantially contributed to the changing of
view of ET in recent years. The traditional view of ET as a
monosymptomatic condition is being replaced by an appreciation of
the spectrum of clinical features and clinical associations, with both
motor and non-motor elements.1,35 It is even possible that ET might
be a family of diseases, unified by the presence of kinetic tremor, but
further characterized by etiological, clinical, and pathological hetero-
geneity.34
The prevalence of ET in NEDICES among persons age 65 and
older was 4.8%.6 This figure is similar to that which has been reported
in other population-based studies.36 The finding that approximately
80% of the ET cases had not been diagnosed previously points to the
fact that this is an underdiagnosed disease.6 Estimates of disease
incidence are difficult to obtain as they require longitudinal data. Prior
to NEDICES, the incidence of ET had been estimated in only one
study.37 That study was based on a retrospective review of medical
records in Rochester, MN, and probably underestimated the true
incidence of ET because entry into the medical record system as an ET
case would have required that the illness was severe enough to be
recognized by the treating physician.37 The incidence estimates from
NEDICES (616 per 100,000 person-years in persons >65 years)10
were substantially higher than those reported using data from the study
in Rochester (incidence 58.6 per 100,000 among those aged 60–69;
76.6 among those aged 70–79; and 84.3 among those >80 years).37
Mortality in ET had not been studied systematically prior to
NEDICES. However, with the presence in some patients of functional
impairments,38 gait difficulty,39 mild cognitive impairment,21 demen-
tia,20,24,25 and increased frailty,40 it was conceivable that ET could
influence the risk of mortality. In one retrospective study, survival of
patients with ET was similar to that of a historical control group.37 In
that study, the mean age at diagnosis was 58 years, and the mean
length of follow-up was 9.7 years; therefore, cases were not all followed
into advanced age, when the risk of mortality in ET is likely to rise.37
By contrast, in the NEDICES study, which enrolled a contemporary
rather than historical control group, the risk of mortality was slightly
but significantly increased in ET cases (adjusted RR51.45, 95%
CI51.01–2.08, p50.04) at 3 years.16 Additional prospective, popula-
tion-based studies are needed.
The NEDICES study demonstrated that ET cases were twice more
likely than controls to report depression and three times more likely to
be taking antidepressant medications.18 In prospective analyses,
baseline self-reported depression was associated with an increased risk
of incident ET.18 These prospective data suggest that the mood
disorder in ET may be more than a secondary response to disease
manifestations; this mood disorder may be a primary feature of the
underlying disease as it is in PD.18
Mild cognitive deficits, mainly in frontal-executive function and
memory, have been reported to occur in ET patients in many
independent studies,41 including NEDICES.19 In line with this, in the
NEDICES study, lower cognitive test scores were associated with more
reported functional difficulty, indicating that lower cognitive test scores
in ET, rather than being clinically inconsequential, seem to have a
clinical–functional correlate.23 In the NEDICES study, baseline
cognitive test scores were lower in non-demented ET cases than
non-demented controls; moreover, during the 3-year follow-up period,
these scores declined at a rate that was seven-times faster in the ET
cases.22 In a second population-based study of elders in New York, ET
was also associated with both increased odds of prevalent dementia
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and increased risk of incident dementia,20 with ORs and RRs similar
to those reported in the NEDICES study.
The relationship between ET and PD has been the subject of
scrutiny and debate for a long time, but there is now growing evidence
that the two tremor disorders are related, at least in some patient
populations.42 The link between ET and incident PD has for the first
time been formally quantified in the NEDICES study, which
demonstrated that the risk of developing incident PD was 4.3 times
higher in prevalent ET cases than in age-matched controls without
ET.26 The NEDICES researchers found another link between both
diseases, the effect of smoking on ET. It has long been known that PD
is inversely associated with smoking cigarettes.43 Using a population-
based, nested case–control design in the NEDICES study, smokers
were nearly half as likely to have ET as those who had never smoked
(adjusted OR50.58, p50.004).28 Furthermore, in the NEDICES
cohort, baseline heavy cigarette smoking was also associated with a
lower risk of incident ET (adjusted RR50.29, p50.03).29
The NEDICES study also examined the effect of alcohol, a well-
known Purkinje cell toxin,44 on the risk of ET. Thus, higher levels of
chronic alcohol consumption were associated with increased the risk of
developing ET.30 Further studies are required to explore whether
higher consumption levels are a continued source of underlying
cerebellar neurotoxicity in patients who already manifest this disease.
Finally, hearing impairment in ET has been examined in the
NEDICES study.27 ET cases reported more hearing impairment than
did matched controls.27 This finding had been found in ET in a
previous clinical series.45 Although the basis for this possible hearing
impairment is unknown, both central and peripheral nervous system
mechanisms have been suggested.27,45
In conclusion, we can say that NEDICES study has been very
important not only for the epidemiology of ET but for the
epidemiology of other aging-related diseases, such as PD, dementia,
and stroke. Its longitudinal design makes it ideal for analyzing risk
factors and mortality. As different diseases have been assessed,
different associations that were not even suspected at the time of the
onset of the study, such as dementia and ET, have been found. This
fact supports its value as a study that has been able to find important
clues about the risk factors for and mechanisms behind neurodegen-
eration and aging.
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References
1. Benito-Leon J, Louis ED. Essential tremor: emerging views of a common
disorder. Nat Clin Pract Neurol 2006;2:666–678, http://dx.doi.org/10.1038/
ncpneuro0347
2. Benito-Leon J, Louis ED. Clinical update: diagnosis and treatment of
essential tremor. Lancet 2007;369:1152–1154, http://dx.doi.org/10.1016/
S0140-6736(07)60544-3.
3. Bermejo-Pareja F, Benito-Leon J, Vega QS, et al. The NEDICES cohort
of the elderly. Methodology and main neurological findings. Rev Neurol 2008;46:
416–423.
4. Vega S, Benito-Leon J, Bermejo-Pareja F, et al. Several factors influenced
attrition in a population-based elderly cohort: neurological disorders in Central
Spain Study. J Clin Epidemiol 2010;63:215–222, http://dx.doi.org/10.1016/j.
jclinepi.2009.03.005.
5. Morales JM, Bermejo FP, Benito-Leon J, et al. Methods and demographic
findings of the baseline survey of the NEDICES cohort: a door-to-door survey
of neurological disorders in three communities from Central Spain. Public Health
2004;118:426–433, http://dx.doi.org/10.1016/j.puhe.2003.10.007.
6. Benito-Leon J, Bermejo-Pareja F, Morales JM, Vega S, Molina JA.
Prevalence of essential tremor in three elderly populations of central Spain. Mov
Disord 2003;18:389–394, http://dx.doi.org/10.1002/mds.10376.
7. Benito-Leon J, Bermejo-Pareja F, Rodriguez J, Molina JA, Gabriel R,
Morales JM. Prevalence of PD and other types of parkinsonism in three elderly
populations of central Spain. Mov Disord 2003;18:267–274, http://dx.doi.org/
10.1002/mds.10362.
8. Diaz-Guzman J, Bermejo-Pareja F, Benito-Leon J, Vega S, Gabriel R,
Medrano MJ. Prevalence of stroke and transient ischemic attack in three elderly
populations of central Spain. Neuroepidemiology 2008;30:247–253, http://dx.doi.
org/10.1159/000135643.
9. Bermejo-Pareja F, Benito-Leon J, Vega S, et al. Consistency of clinical
diagnosis of dementia in NEDICES: a population-based longitudinal study in
Spain. J Geriatr Psychiatry Neurol 2009;22:246–255, http://dx.doi.org/10.1177/
0891988709335794.
10. Benito-Leon J, Bermejo-Pareja F, Louis ED. Incidence of essential
tremor in three elderly populations of central Spain. Neurology 2005;64:1721–
1725, http://dx.doi.org/10.1212/01.WNL.0000161852.70374.01.
11. Benito-Leon J, Bermejo-Pareja F, Morales-Gonzalez JM, et al. Incidence
of Parkinson disease and parkinsonism in three elderly populations of central
Spain. Neurology 2004;62:734–741, http://dx.doi.org/10.1212/01.WNL.
0000113727.73153.68.
12. Martinez-Salio A, Benito-Leon J, Diaz-Guzman J, Bermejo-Pareja F.
Cerebrovascular disease incidence in central Spain (NEDICES): a population-
based prospective study. J Neurol Sci 2010;298:85–90, http://dx.doi.org/10.
1016/j.jns.2010.08.003.
13. Bermejo-Pareja F, Benito-Leon J, Vega S, Medrano MJ, Roman GC.
Incidence and subtypes of dementia in three elderly populations of central
Spain. J Neurol Sci 2008;264:63–72, http://dx.doi.org/10.1016/j.jns.2007.07.
021.
14. Salemi G, Savettieri G, Rocca WA, et al. Prevalence of essential tremor:
a door-to-door survey in Terrasini, Sicily. Sicilian Neuro-Epidemiologic Study
Group. Neurology 1994;44:61–64, http://dx.doi.org/10.1212/WNL.44.1.61.
The NEDICES Study and Essential Tremor Romero JP, Benito-León J, Bermejo-Pareja F
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services7
15. Louis ED, Ford B, Lee H, Andrews H, Cameron G. Diagnostic criteria
for essential tremor: a population perspective. Arch Neurol 1998;55:823–828,
http://dx.doi.org/10.1001/archneur.55.6.823.
16. Louis ED, Benito-Leon J, Ottman R, Bermejo-Pareja F. A population-
based study of mortality in essential tremor. Neurology 2007;69:1982–1989,
http://dx.doi.org/10.1212/01.wnl.0000279339.87987.d7.
17. Louis ED, Benito-Leon J, Vega S, Bermejo-Pareja F. Frailty in elderly
persons with essential tremor: a population-based study (NEDICES). Eur J
Neurol 2011;18:1251–1257, http://dx.doi.org/10.1111/j.1468-1331.2011.
03374.x.
18. Louis ED, Benito-Leon J, Bermejo-Pareja F. Self-reported depression
and anti-depressant medication use in essential tremor: cross-sectional and
prospective analyses in a population-based study. Eur J Neurol 2007;14:1138–
1146, http://dx.doi.org/10.1111/j.1468-1331.2007.01923.x.
19. Benito-Leon J, Louis ED, Bermejo-Pareja F. Population-based case-
control study of cognitive function in essential tremor. Neurology 2006;66:69–74,
http://dx.doi.org/10.1212/01.wnl.0000192393.05850.ec.
20. Thawani SP, Schupf N, Louis ED. Essential tremor is associated with
dementia: prospective population-based study in New York. Neurology 2009;73:
621–625, http://dx.doi.org/10.1212/WNL.0b013e3181b389f1.
21. Benito-Leon J, Louis ED, Mitchell AJ, Bermejo-Pareja F. Elderly-onset
essential tremor and mild cognitive impairment: a population-based study
(NEDICES). J Alzheimers Dis 2011;23:727–735.
22. Louis ED, Benito-Leon J, Vega-Quiroga S, Bermejo-Pareja F. Faster
rate of cognitive decline in essential tremor cases than controls: a prospective
study. Eur J Neurol 2010;17:1291–1297, http://dx.doi.org/10.1111/j.1468-
1331.2010.03122.x.
23. Louis ED, Benito-Leon J, Vega-Quiroga S, Bermejo-Pareja F. Cognitive
and motor functional activity in non-demented community-dwelling essential
tremor cases. J Neurol Neurosurg Psychiatry 2010;81:997–1001, http://dx.doi.org/
10.1136/jnnp.2009.202838.
24. Benito-Leon J, Louis ED, Bermejo-Pareja F. Elderly-onset essential
tremor is associated with dementia. Neurology 2006;66:1500–1505, http://dx.
doi.org/10.1212/01.wnl.0000216134.88617.de.
25. Bermejo-Pareja F, Louis ED, Benito-Leon J. Risk of incident dementia in
essential tremor: a population-based study. Mov Disord 2007;22:1573–1580,
http://dx.doi.org/10.1002/mds.21553.
26. Benito-Leon J, Louis ED, Bermejo-Pareja F. Risk of incident Parkinson’s
disease and parkinsonism in essential tremor: a population based study. J Neurol
Neurosurg Psychiatry 2009;80:423–425, http://dx.doi.org/10.1136/jnnp.2008.
147223.
27. Benito-Leon J, Louis ED, Bermejo-Pareja F. Reported hearing
impairment in essential tremor: a population-based case-control study.
Neuroepidemiology 2007;29:213–217, http://dx.doi.org/10.1159/000112463.
28. Benito-Leon J, Louis ED, Bermejo-Pareja F. Population-based case-
control study of cigarette smoking and essential tremor. Mov Disord 2008;23:
246–252, http://dx.doi.org/10.1002/mds.21810.
29. Louis ED, Benito-Leon J, Bermejo-Pareja F. Population-based
prospective study of cigarette smoking and risk of incident essential tremor.
Neurology 2008;70:1682–1687, http://dx.doi.org/10.1212/01.wnl.0000311271.
42596.32.
30. Louis ED, Benito-Leon J, Bermejo-Pareja F. Population-based study of
baseline alcohol consumption and risk of incident essential tremor. J Neurol
Neurosurg Psychiatry 2009;80:494–497, http://dx.doi.org/10.1136/jnnp.2008.
162701.
31. Frishman WH. Are antihypertensive agents protective against dementia?
A review of clinical and preclinical data. Heart Dis 2002;4:380–386, http://dx.
doi.org/10.1097/00132580-200211000-00007.
32. Louis ED, Benito-Leon J, Bermejo-Pareja F. Antihypertensive agents
and risk of Parkinson’s disease, essential tremor and dementia: a population-
based prospective study (NEDICES). Neuroepidemiology 2009;33:286–292, http://
dx.doi.org/10.1159/000235641.
33. Louis ED, Thawani SP, Andrews HF. Prevalence of essential tremor in a
multiethnic, community-based study in northern Manhattan, New York, N.Y.
Neuroepidemiology 2009;32:208–214, http://dx.doi.org/10.1159/000195691.
34. Louis ED. Essential tremor: evolving clinicopathological concepts in an
era of intensive post-mortem enquiry. Lancet Neurol 2010;9:613–622, http://dx.
doi.org/10.1016/S1474-4422(10)70090-9.
35. Louis ED. Essential tremors: a family of neurodegenerative disorders?
Arch Neurol 2009;66:1202–1208, http://dx.doi.org/10.1001/archneurol.2009.
217.
36. Louis ED, Ferreira JJ. How common is the most common adult
movement disorder? Update on the worldwide prevalence of essential tremor.
Mov Disord 2010;25:534–541, http://dx.doi.org/10.1002/mds.22838.
37. Rajput AH, Offord KP, Beard CM, Kurland LT. Essential tremor in
Rochester, Minnesota: a 45-year study. J Neurol Neurosurg Psychiatry 1984;47:
466–470, http://dx.doi.org/10.1136/jnnp.47.5.466.
38. Louis ED, Barnes L, Albert SM, et al. Correlates of functional disability
in essential tremor. Mov Disord 2001;16:914–920, http://dx.doi.org/10.1002/
mds.1184.
39. Stolze H, Petersen G, Raethjen J, Wenzelburger R, Deuschl G. The gait
disorder of advanced essential tremor. Brain 2001;124:2278–2286, http://dx.
doi.org/10.1093/brain/124.11.2278.
40. Louis ED, Benito-León J, Vega S, Bermejo-Pareja F. Neurological
Disorders in Central Spain (NEDICES) Study Group. Frailty in elderly persons
with essential tremor: a population-based study (NEDICES). Eur J Neurol 2011;
18:1251–1257, http://dx.doi.org/10.1111/j.1468-1331.2011.03374.x.
41. Labiano-Fontcuberta A, Benito-León J, Bermejo-Pareja F. Neuro-
psychiatric disturbances in essential tremor. Med Clin (Barc) 2012;138:171–176.
42. Louis ED, Frucht SJ. Prevalence of essential tremor in patients with
Parkinson’s disease vs. Parkinson-plus syndromes. Mov Disord 2007;22:1402–
1407, http://dx.doi.org/10.1002/mds.21383.
43. Ritz B, Ascherio A, Checkoway H, et al. Pooled analysis of tobacco use
and risk of Parkinson disease. Arch Neurol 2007;64:990–997, http://dx.doi.org/
10.1001/archneur.64.7.990.
44. Andersen BB. Reduction of Purkinje cell volume in cerebellum of
alcoholics. Brain Res 2004;1007:10–18, http://dx.doi.org/10.1016/j.brainres.
2004.01.058.
45. Ondo WG, Sutton L, Dat Vuong K, Lai D, Jankovic J. Hearing
impairment in essential tremor. Neurology 2003;61:1093–1097, http://dx.doi.
org/10.1212/01.WNL.0000086376.40750.AF.
Romero JP, Benito-León J, Bermejo-Pareja F The NEDICES Study and Essential Tremor
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services8
